CITI/CALL/PFIZER INC/32/0.1/19.06.25 Stock

Warrant

DE000KH9RQN2

Market Closed - Boerse Frankfurt Warrants 01:35:37 2024-07-12 pm EDT
0.16 EUR +6.67% Intraday chart for CITI/CALL/PFIZER INC/32/0.1/19.06.25
Current month+23.08%
1 month+23.08%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 0.16 +6.67%
24-07-11 0.15 +15.38%
24-07-10 0.13 +8.33%
24-07-09 0.12 0.00%
24-07-08 0.12 -7.69%

Real-time Boerse Frankfurt Warrants

Last update July 12, 2024 at 01:35 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Citi Citi
WKN KH9RQN
ISINDE000KH9RQN2
Date issued 2023-09-13
Strike 32 $
Maturity 2025-06-19 (342 Days)
Parity 10 : 1
Emission price 0.53
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.56
Lowest since issue 0.089

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.92 USD
Average target price
32.1 USD
Spread / Average Target
+10.99%
Consensus